Beruflich Dokumente
Kultur Dokumente
doi:10.1111/anae.12879
Original Article
Use of hyaluronidase as an adjuvant to ropivacaine to reduce
axillary brachial plexus block onset time: a prospective,
randomised controlled study
W. U. Koh,1 H. G. Min,1 H. S. Park,2 M. H. Karm,2 K. K. Lee,3 H. S. Yang4 and Y. J. Ro4
1 Clinical Assistance Professor, 2 Resident, 3 Clinical Lecturer, 4 Professor, Department of Anesthesiology and Pain
Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea
Summary
When considering brachial plexus block as a practical alternative to general anaesthesia for upper limb surgery, the
time to achieve complete sensory block is a clinically important variable. In this prospective randomised double-blind
controlled trial, we investigated the hypothesis that addition of hyaluronidase to ropivacaine may reduce the time to
achieve complete sensory block after axillary brachial plexus block. The patients were randomly assigned into a hyaluronidase group (n = 24) and a control group (n = 24). The hyaluronidase group received ropivacaine 0.5% with
100 IU.ml 1 of hyaluronidase, and the control group received ropivacaine alone. The primary endpoint was the time
to achieve complete sensory block. The hyaluronidase group demonstrated signicantly shorter mean (SD) sensory
block onset time (13.8 (6.0) min) compared with the control group (22.5 (6.3) min, p < 0.0001). Addition of hyaluronidase to ropivacaine resulted in a reduction in the time needed to achieve complete sensory block.
.................................................................................................................................................................
Introduction
Brachial plexus blocks are useful for anaesthesia and
postoperative pain control in surgery performed on
the upper limbs [1, 2]. The axillary approach blocks
the brachial plexus at the terminal branch and provides anaesthesia suitable for surgery performed on the
forearm [3, 4]. The axillary brachial plexus is supercial in location, and has no risk of complications such
as pneumothorax or phrenic nerve paralysis that can
occur with other brachial plexus approaches [3, 5].
The widespread use of ultrasound guidance and nerve
stimulation has improved the reliability of axillary brachial plexus blocks, yielding higher success rates with a
reduced number of needle passes [6, 7]. Time to
282
Methods
This prospective, randomised, double-blind, singlecentre trial was conducted at the Asan Medical Center
in Seoul, Republic of Korea. Permission to conduct this
study was approved by the Institutional Review Board of
Asan Medical Center, and written informed consent was
received from each patient who participated in the
study. This study was registered at the Clinical Research
Information Service (cris.nih.go.kr/KCT0000964).
Adult patients (> 19 years of age) scheduled for
elective surgery of the forearm and hand who were
classied as ASA physical status 12 were considered
eligible for inclusion in the study. Patients presenting
with neurological decits of the upper arm, severe coagulopathy, chronic obstructive pulmonary disease,
cardiopulmonary compromise, chronic renal failure,
cerebral vascular disease, pregnancy, chronic corticosteroid use, hypersensitivity to hyaluronidase or local
anaesthetics or local infection at the site of the axillary
block were excluded from the study.
After enrolment, patients were randomly assigned
into two treatment groups: a hyaluronidase group and a
control group. A computer-generated randomisation
program was used, and patients were allocated just
before performing the block. Study drugs were prepared
in unidentiable syringes by a staff member who was
not involved in the study. The hyaluronidase group
received ropivacaine mixed 0.5% with 100 IU.ml 1
hyaluronidase (H-LASE; KuhnilPharm, Seoul, Korea)
for the axillary brachial plexus block, with the total dose
of hyaluronidase not exceeding 3000 IU. The control
group received ropivacaine 0.5% alone.
All blocks were performed in the operating room
by the rst author (WUK). Patients were not premedicated and standard monitors including electrocardiography, non-invasive arterial pressure and pulse
oximetry were used. Five litres.min 1 of oxygen were
delivered via a facemask and 1 mg midazolam and
50 lg fentanyl were administered intravenously
(regardless of age or weight) for patient comfort during the block procedure.
Subjects were positioned supine with the head
turned to the contralateral side and the ipsilateral arm
2014 The Association of Anaesthetists of Great Britain and Ireland
abducted with the elbow exed. The skin was disinfected and inltrated with lidocaine 1% before block needle insertion. After sterile drapes were applied, the
ultrasound probe was positioned vertically in the axilla
to obtain a short-axis view of the axillary artery. A 15
16 MHz high-frequency linear array transducer
(HGL50x; SonoSite, Bothell, WA, USA) and ultrasound
system (S-NerveTM; SonoSite) were used. The probe
position was further adjusted to achieve a clear view of
the musculocutaneous nerve on the left side of the
ultrasound screen and the axillary artery in the middle
or slightly to the right side of the screen. For musculocutaneous blockade and axillary brachial plexus block,
skin puncture was generally performed once, although
skin puncture was performed twice in patients where
the musculocutaneous nerve was identied in a deep
position or with a large muscle bulk. Using real-time
ultrasound guidance, a 22-G, 60-mm stimulating needle (StimuplexD; B.Braun AG, Melsungen, Germany)
was advanced in-plane initially towards the musculocutaneous nerve. A nerve stimulator (MultiStim SENSOR; PAJUNKGmbH Medizintechnologie, Geisingen,
Germany) was used to localise the nerves using an
electrical current of 0.30.5 mA while observing
twitches of the corresponding muscle, and 57 ml
ropivacaine 0.5% with or without hylauronidase was
injected around the nerve. The needle was then
advanced to a four to six oclock position (radial
nerve) relative to the axillary artery and after conrmation by nerve stimulation, 510 ml local anaesthetic
was delivered. The needle was withdrawn and
advanced to the two (ulnar nerve) and 10 (median
nerve) oclock positions and 57 ml local anaesthetic
was sequentially injected in both positions [6, 13].
All surgery was performed with axillary brachial
plexus block as the sole anaesthetic technique. The need
for a supplementary block or conversion to general
anaesthesia was determined by the attending anaesthetist 30 min after the last local anaesthetic injection. During the 30-min observation period, any signs of systemic
local toxicity were observed and managed (if present).
The surgeon, blinded to the treatment group, determined the need for additional local anaesthetic inltration at the surgical site. After the operation, patients
were taken to the post-anaesthetic care unit for recovery
and then moved to a general ward or discharged.
283
received general anaesthesia due to surgical requirement for iliac bone grafts. One patient in the control
group required conversion to general anaesthesia
because of an incomplete block, while one patient in
the hyaluronidase group showed signs of mild systemic
local toxicity a few minutes after local anaesthetic
injection and was given additional midazolam, making
any further data collection impossible due to oversedation. As a consequence, 24 patients who successfully
completed the study protocol were enrolled in each
group. There were no differences in patient and surgical characteristics between the two study groups
(Table 1). The site of surgery (bone or soft tissue) was
evenly distributed between the two study groups.
Time to achieve complete sensory block, time to
reach surgical anaesthesia and the total performance
time were signicantly lower in the hyaluronidase
group (Table 2, Fig. 1). There was no difference in
Results
Between November 2013 and March 2014, 80 patients
who presented for elective hand or forearm surgery
were screened for eligibility. Eighteen patients met the
exclusion criteria and nine patients refused to participate, while 53 patients agreed to participate in the
study. A further three patients were removed as they
Table 1 Characteristics of patients receiving axillary brachial plexus block with and without hyaluronidase, and the
surgery undergone. Values are number (proportion) or mean (SD).
Sex; M:F
Age; years
Height; cm
Weight; kg
Surgery
Left:right
Hand:forearm
Soft tissue:bone
Duration of surgery; min
Hyaluronidase
(n = 24)
Control
(n = 24)
9
55.1
160.1
64.3
(37.5%):15 (62.5%)
(14.1)
(10.1)
(12.1)
14
54.6
162.0
64.4
(58.3%):10 (41.7%)
(17.2)
(10.8)
(14.4)
10
7
11
70.7
(41.7%):14 (58.3%)
(29.2%):17 (70.8%)
(45.8%):13 (54.2%)
(32.6)
12
8
11
74
(50%):12 (50%)
(33.3%):16 (66.7%)
(45.8%):13 (54.2%)
(35.2)
Table 2 Block performance and placement details for patients receiving axillary brachial plexus block with and without hyaluronidase. Values are median (IQR [range]), mean (SD) or number (proportion).
Hyaluronidase
(n = 24)
Control
(n = 24)
p value
6
13.8
15.6
21.8
23
1
0
54.2
3.3
2.2
138.8
5.5
22.5
22.5
29.9
20
2
1
57.3
3.2
2.2
134.8
0.776
< 0.0001
0.00074
< 0.0001
0.348
1.000
1.000
0.419
0.726
0.617
0.450
(56.75 [49])
(6.0)
(6.3)
(6.2)
(95.8%)
(14.1)
(0.9)
(0.5)
(16.7)
(47 [410])
(6.3)
(6.9)
(5.8)
(83.3%)
(0.1%)
(17.3)
(1.1)
(0.5)
(18.8)
285
Figure 1 KaplanMeier survival plot of proportion of patients who achieved (a) a complete sensory block and (b)
surgical anaesthesia after axillary brachial plexus block with (solid line) and without (dashed line) hyaluronidase.
p < 0.001 vs control.
needling time, the number of patients under surgical
anaesthesia after 30 min or the number of patients
who required supplemental blocks (Table 2). The total
amount of fentanyl, midazolam and ropivacaine
administered was similar between the two groups
(Table 2).
The duration of the sensory block was shorter in
the hyaluronidase group than in the control group
(Table 3). The duration of the motor block was also
Table 3 Block duration, analgesic duration, postoperative analgesic requirements, and patient satisfaction with anaesthesia after axillary brachial plexus block with and without hyaluronidase. Values are mean (SD) or number (proportion).
286
Hyaluronidase
(n = 24)
Control
(n = 24)
p value
535.9 (200.2)
558.4 (235.4)
610.2 (237.4)
671.7 (148.1)
670.4 (218.7)
759 (206.2)
0.010
0.094
0.074
18
11
17
10
47.9
19.6
(75%)
(45.8%)
(70.8%)
(41.7%)
(37.5)
(24.4)
6.75 (0.44)
17
9
13
8
37.5
13.5
(70.8%)
(37.5%)
(54.2%)
(33.3%)
(39.7)
(20)
6.42 (0.97)
1.000
0.770
0.371
0.766
0.332
0.490
0.259
Discussion
In the present study, the addition of 100 IU.ml 1 of
hyaluronidase to ropivacaine 0.5% signicantly shortened the time to achieve complete sensory block and
surgical anaesthesia, therefore reducing the anaesthetic
time before the start of the operation. The number of
patients requiring supplementary block or additional
analgesia was similar between the two groups. The use
of hyaluronidase reduced the duration of the sensory
block. The duration of motor block and ropivacaine
brachial plexus block analgesia were also reduced, but
this did not achieve statistical signicance. There was
no difference in the total administered dose of postoperative analgesic medication.
Reducing the time to reach complete sensory block
has practical advantages, as the turnover time between
operations can be optimised and operation rooms can
2014 The Association of Anaesthetists of Great Britain and Ireland
Competing interests
No external funding or competing interests declared.
References
1. Choi S, Rodseth R, McCartney CJ. Effects of dexamethasone as
a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta-analysis of randomized trials. British
Journal of Anaesthesia 2014; 112: 42739.
2. Song IA, Gil NS, Choi EY, et al. Axillary approach versus the
infraclavicular approach in ultrasound-guided brachial plexus
block: comparison of anesthetic time. Korean Journal of Anesthesiology 2011; 61: 128.
3. Nadeau MJ, Levesque S, Dion N. Ultrasound-guided regional
anesthesia for upper limb surgery. Canadian Journal of Anesthesia 2013; 60: 30420.
4. Bernucci F, Gonzalez AP, Finlayson RJ, Tran de QH. A prospective, randomized comparison between perivascular and perineural ultrasound-guided axillary brachial plexus block.
Regional Anesthesia and Pain Medicine 2012; 37: 4737.
5. Brown DL, Cahill DR, Bridenbaugh LD. Supraclavicular nerve
block: anatomic analysis of a method to prevent pneumothorax. Anesthesia and Analgesia 1993; 76: 5304.
6. de Tran QH, Pham K, Dugani S, Finlayson RJ. A prospective,
randomized comparison between double-, triple-, and quadruple-injection ultrasound-guided axillary brachial plexus
block. Regional Anesthesia and Pain Medicine 2012; 37: 248
53.
7. Sites BD, Beach ML, Spence BC, et al. Ultrasound guidance
improves the success rate of a perivascular axillary plexus
block. Acta Anaesthesiologica Scandinavica 2006; 50: 67884.
8. Fredrickson MJ, Patel A, Young S, Chinchanwala S. Speed of
onset of corner pocket supraclavicular and infraclavicular
ultrasound guided brachial plexus block: a randomised observer-blinded comparison. Anaesthesia 2009; 64: 73844.
9. Minville V, Amathieu R, Luc N, et al. Infraclavicular brachial
plexus block versus humeral approach: comparison of anesthetic time and efficacy. Anesthesia and Analgesia 2005; 101:
1198201.
10. Nathan N, Benrhaiem M, Lotfi H, et al. The role of hyaluronidase on lidocaine and bupivacaine pharmacokinetics after
peribulbar blockade. Anesthesia and Analgesia 1996; 82:
10604.
11. Lewis-Smith PA. Adjunctive use of hyaluronidase in local
anaesthesia. British Journal of Plastic Surgery 1986; 39: 5548.
12. Dunn AL, Heavner JE, Racz G, Day M. Hyaluronidase: a review
of approved formulations, indications and off-label use in
chronic pain management. Expert Opinion on Biological Therapy 2010; 10: 12731.
13. de Tran QH, Russo G, Munoz L, Zaouter C, Finlayson RJ. A prospective, randomized comparison between ultrasound-guided
supraclavicular, infraclavicular, and axillary brachial plexus
blocks. Regional Anesthesia and Pain Medicine 2009; 34:
36671.
14. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical
importance of changes in chronic pain intensity measured on
an 11-point numerical pain rating scale. Pain 2001; 94: 149
58.
15. Van Zundert J, Patijn J, Kessels A, Lame I, van Suijlekom H,
van Kleef M. Pulsed radiofrequency adjacent to the cervical
dorsal root ganglion in chronic cervical radicular pain: a double blind sham controlled randomized clinical trial. Pain 2007;
127: 17382.
2014 The Association of Anaesthetists of Great Britain and Ireland
289